Biden Administration COVID-19 response

4 Results / Page 1 of 1

Background

Health & Wellness

“Test To Treat” Sites with Free COVID-19 Antiviral Pills are Rolling Out across the U.S.

CNN reports that the rollout of the U.S. government's COVID-19 "Test-to-Treat" program is underway, with in-pharmacy clinics ordering shipments of COVID-19 antiviral medications and some locations expecting to offer the service within days. Last week, in its new National COVID-19 Preparedness Plan, the White House announced the Test-to-Treat initiative, in which people can visit "one-stop" sites that offer free COVID-19 testing and that prescribe free antiviral pills on the spot […]

todayMarch 14, 2022

Health & Wellness

Biden announces initiative to give Americans Free Antiviral Treatment after Positive Covid Test

President Biden announced during his State of the Union address on Tuesday that individuals who test positive for COVID-19 at a pharmacy will soon be able to get free antiviral treatments immediately after. The President stated, "We've ordered more pills than anyone in the world has. Pfizer is working overtime to get us a million pills this month and more than double that next month," Biden said. "And now we're […]

todayMarch 3, 2022

Health & Wellness

Biden Administration to send 500 Million Free At-Home COVID Tests Directly to Americans and Ramps up COVID-19 Winter Strategy

Fighting the omicron variant surging through the country, President Joe Biden announced the government will provide 500 million free rapid home-testing kits, increase support for hospitals under strain and redouble vaccination and boosting efforts. At the White House on Tuesday, Biden detailed major changes to his COVID-19 winter plan, his hand forced by the fast-spreading variant, whose properties are not yet fully understood by scientists. Yet his message was clear […]

todayDecember 23, 2021

Health & Wellness

FDA set to approve Pfizer Vaccine for Kids between Ages 5 and 11

AP and Reuters report that U.S. health regulators said late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the U.S. weighs beginning vaccinations in youngsters. The Food and Drug Administration (FDA) posted its analysis of Pfizer’s data ahead of a public meeting next week to debate whether the shots are ready for […]

todayOctober 25, 2021

Subscribe

LISTEN WITH YOUR APP

0%